Avenir Wellness Solutions, Inc.
company.status.inactiveCIK 1643301fmd_19WWBN54EBWGPCM84YAK3C761GManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Sep 30, 2024, 41 periods
| Line item | FY2015 | FY2016 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | – | – | 0 | 1 | 1 | 2 | 6 | 5 | 4 |
| Cost of revenue | 0 | – | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 1 |
| Gross profit | 0 | – | (0) | (0) | 0 | 0 | 1 | 4 | 3 | 3 |
| Research and development | 1 | – | 1 | 1 | 1 | 2 | 3 | 2 | 0 | 0 |
| Selling, general and administrative | 1 | – | 3 | 6 | 6 | 10 | 11 | 16 | 12 | 9 |
| Policy acquisition costs | – | – | 0 | 0 | 0 | 0 | – | – | – | – |
| Total operating expenses | – | 0 | – | 7 | 8 | 14 | 20 | 15 | 22 | 9 |
| Operating income | (2) | – | (4) | (7) | (8) | (14) | (19) | (10) | (18) | (6) |
| Interest expense | 0 | – | 0 | 2 | (3) | 0 | 2 | 0 | 0 | 0 |
| Interest and investment income | 0 | – | 0 | 0 | – | – | – | – | – | – |
| Other non-operating income (expense) | (0) | – | (0) | (1) | (3) | (8) | (12) | 2 | (0) | 2 |
| Income before taxes | (2) | – | (4) | (8) | (10) | (21) | (31) | (9) | (18) | (3) |
| Income tax expense | – | – | – | – | – | 0 | 0 | 0 | (0) | (0) |
| Net income from continuing operations | – | – | – | – | (12) | (21) | (31) | (13) | (19) | (3) |
| Net income | (2) | – | (4) | (8) | (10) | (21) | (31) | (13) | (26) | (3) |
| Net income to common shareholders | – | – | – | (8) | (10) | (21) | – | – | – | – |